INMUNE BIO INC's ticker is and the CUSIP is 45782T955. A total of 3 filers reported holding INMUNE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,560 | -24.7% | 9,000 | 0.0% | 0.00% | – |
| Q2 2023 | $81,720 | +43.2% | 9,000 | 0.0% | 0.00% | – |
| Q4 2022 | $57,060 | -85.7% | 9,000 | -80.0% | 0.00% | -100.0% |
| Q2 2022 | $398,000 | +2241.2% | 45,000 | +2150.0% | 0.00% | – |
| Q1 2022 | $17,000 | -10.5% | 2,000 | +5.3% | 0.00% | – |
| Q4 2021 | $19,000 | -76.2% | 1,900 | -53.7% | 0.00% | – |
| Q3 2021 | $80,000 | +281.0% | 4,100 | +241.7% | 0.00% | – |
| Q2 2021 | $21,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |